147 related articles for article (PubMed ID: 35037240)
21. TMTV-Net: fully automated total metabolic tumor volume segmentation in lymphoma PET/CT images - a multi-center generalizability analysis.
Yousefirizi F; Klyuzhin IS; O JH; Harsini S; Tie X; Shiri I; Shin M; Lee C; Cho SY; Bradshaw TJ; Zaidi H; Bénard F; Sehn LH; Savage KJ; Steidl C; Uribe CF; Rahmim A
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1937-1954. PubMed ID: 38326655
[TBL] [Abstract][Full Text] [Related]
22. Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden.
Leccisotti L; Maccora D; Malafronte R; D'Alò F; Maiolo E; Annunziata S; Rufini V; Giordano A; Hohaus S
J Cancer Res Clin Oncol; 2023 Jul; 149(7):2783-2791. PubMed ID: 35779106
[TBL] [Abstract][Full Text] [Related]
23. A nomogram for predicting the rapid progression of diffuse large B-cell lymphoma established by combining baseline PET/CT total metabolic tumor volume, lesion diffusion, and TP53 mutations.
Liu C; Shi P; Li Z; Li B; Li Z
Cancer Med; 2023 Aug; 12(16):16734-16743. PubMed ID: 37366281
[TBL] [Abstract][Full Text] [Related]
24. Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial.
Cottereau AS; Rebaud L; Trotman J; Feugier P; Nastoupil LJ; Bachy E; Flinn IW; Haioun C; Ysebaert L; Bartlett NL; Tilly H; Casasnovas O; Ricci R; Portugues C; Buvat I; Meignan M; Morschhauser F
Ann Oncol; 2024 Jan; 35(1):130-137. PubMed ID: 37898239
[TBL] [Abstract][Full Text] [Related]
25. Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma.
Cottereau AS; Lanic H; Mareschal S; Meignan M; Vera P; Tilly H; Jardin F; Becker S
Clin Cancer Res; 2016 Aug; 22(15):3801-9. PubMed ID: 26936916
[TBL] [Abstract][Full Text] [Related]
26. Deep learning-based tumour segmentation and total metabolic tumour volume prediction in the prognosis of diffuse large B-cell lymphoma patients in 3D FDG-PET images.
Jiang C; Chen K; Teng Y; Ding C; Zhou Z; Gao Y; Wu J; He J; He K; Zhang J
Eur Radiol; 2022 Jul; 32(7):4801-4812. PubMed ID: 35166895
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the prognostic value of different methods of calculating the tumour metabolic volume with
Guzmán Ortiz S; Mucientes Rasilla J; Vargas Núñez JA; Royuela A; Navarro Matilla B; Mitjavila Casanovas M
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(6):340-346. PubMed ID: 32646783
[TBL] [Abstract][Full Text] [Related]
28. Metabolic tumour volume in Hodgkin lymphoma-A comparison between manual and AI-based analysis.
Sadik M; Barrington SF; Trägårdh E; Saboury B; Nielsen AL; Jakobsen AL; Gongora JLL; Urdaneta JL; Kumar R; Edenbrandt L
Clin Physiol Funct Imaging; 2024 May; 44(3):220-227. PubMed ID: 38011940
[TBL] [Abstract][Full Text] [Related]
29. Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trial.
Schmitz C; Rekowski J; Müller SP; Hertenstein B; Franzius C; Ganser A; Bengel FM; Kroschinsky F; Kotzerke J; La Rosée P; Freesmeyer M; Hoeffkes HG; Hertel A; Behringer D; Mesters R; Weckesser M; Mahlmann S; Haberkorn U; Martens U; Prange-Krex G; Brenner W; Giagounidis A; Moeller R; Runde V; Sandmann M; Hautzel H; Wilop S; Krohn T; Dürk H; Heike M; Alashkar F; Brinkmann M; Trenn G; Wacker D; Kreisel-Büstgens C; Bernhard H; Heil G; Larisch R; Kurch L; Jöckel KH; Hoelzer D; Klapper W; Boellaard R; Dührsen U; Hüttmann A
Hematol Oncol; 2020 Aug; 38(3):244-256. PubMed ID: 32067259
[TBL] [Abstract][Full Text] [Related]
30. Metabolic tumor burden on baseline
Chen S; He K; Feng F; Wang S; Yin Y; Fu H; Wang H
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1830-1839. PubMed ID: 31187163
[TBL] [Abstract][Full Text] [Related]
31. A better prediction of progression-free survival in diffuse large B-cell lymphoma by a prognostic model consisting of baseline TLG and %ΔSUV
Zhang YY; Song L; Zhao MX; Hu K
Cancer Med; 2019 Sep; 8(11):5137-5147. PubMed ID: 31343111
[TBL] [Abstract][Full Text] [Related]
32. Combined positron emission tomography/computed tomography for diagnosis and monitoring of orbital adnexal lymphoma.
Klingenstein A; Garip-Kuebler A; Mueller-Lisse UG; Hintschich C
Acta Ophthalmol; 2018 Sep; 96(6):e712-e717. PubMed ID: 30146694
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of baseline
Zhou Y; Hong Z; Zhou M; Sang S; Zhang B; Li J; Li Q; Wu Y; Deng S
J Med Imaging Radiat Oncol; 2020 Feb; 64(1):87-95. PubMed ID: 31880103
[TBL] [Abstract][Full Text] [Related]
34.
Girum KB; Rebaud L; Cottereau AS; Meignan M; Clerc J; Vercellino L; Casasnovas O; Morschhauser F; Thieblemont C; Buvat I
J Nucl Med; 2022 Dec; 63(12):1925-1932. PubMed ID: 35710733
[TBL] [Abstract][Full Text] [Related]
35. Value of baseline and end of chemotherapy
Xiao Z; Mo Y; Long W; Li R; Li X; Wei Y; Fan W; Zhang X
Leuk Lymphoma; 2021 Dec; 62(12):2873-2881. PubMed ID: 34165390
[TBL] [Abstract][Full Text] [Related]
36. Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study.
Kostakoglu L; Mattiello F; Martelli M; Sehn LH; Belada D; Ghiggi C; Chua N; González-Barca E; Hong X; Pinto A; Shi Y; Tatsumi Y; Bolen C; Knapp A; Sellam G; Nielsen T; Sahin D; Vitolo U; Trněný M
Haematologica; 2022 Jul; 107(7):1633-1642. PubMed ID: 34407602
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a convolution neural network for baseline total tumor metabolic volume on [
Karimdjee M; Delaby G; Huglo D; Baillet C; Willaume A; Dujardin S; Bailliez A
Eur Radiol; 2023 May; 33(5):3386-3395. PubMed ID: 36600126
[TBL] [Abstract][Full Text] [Related]
38. Positron emission tomography/computed tomography in the management of Hodgkin and B-cell non-Hodgkin lymphoma: An update.
Juweid ME; Mueller M; Alhouri A; A-Risheq MZ; Mottaghy FM
Cancer; 2021 Oct; 127(20):3727-3741. PubMed ID: 34286864
[No Abstract] [Full Text] [Related]
39. Semi-automated
Keijzer K; Niezink AGH; de Boer JW; van Doesum JA; Noordzij W; van Meerten T; van Dijk LV
Comput Struct Biotechnol J; 2023; 21():1102-1114. PubMed ID: 36789266
[TBL] [Abstract][Full Text] [Related]
40. Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma.
Ilyas H; Mikhaeel NG; Dunn JT; Rahman F; Møller H; Smith D; Barrington SF
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1142-1154. PubMed ID: 29460024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]